Advertisement
Advertisement

AARD

AARD logo

Aardvark Therapeutics, Inc. Common Stock

7.90
USD
Sponsored
+0.60
+8.22%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

7.80

-0.10
-1.27%

Aardvark Therapeutics, Inc. Common Stock Profile

About

Aardvark Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. The company's lead product candidate includes ARD-101. Aardvark Therapeutics Inc. is based in SAN DIEGO.

Info & Links

CEO

Tien-Li Lee

Headquarters

4370 La Jolla Village Drive, Suite 1050
San Diego, CA 92122, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://aardvarktherapeutics.com

Auditor

BDO USA, P.C

Share holders

--

Employees

40

Aardvark Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

170.70M

Enterprise Value

108.26M

Enterprise Value/EBITDA(ttm)

-1.42

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.98

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-61.71%

Return on Invested Capital(ttm)

-65.15%

Return on Assets(ttm)

-56.29%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-76.02M

Net Income Available to Common(ttm)

-69.87M

Diluted EPS(ttm)

-3.21

Share Statistics

Beta (5Y Monthly)

3.81

52-Week Change

-34.11%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

21.82M

Dividend Yield

0.00%

Float4

17.99M

% Held by Insiders

17.80%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

91.20M

Total Cash Per Share(mrq)

4.18

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.06%

Quick Ratio(mrq)

8.06%

Book Value Per Share(mrq)

3.99

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.86

Free Cash Flow(ytd)

-18.87M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement